Zinnat

22.03.2018 Updated 22.10.2019 18702 views

By MoH of Ukraine order No. 290 of 20.02.2018, the instructions for medical use (hereinafter, the instructions) of the original (reference) medicinal product containing cefuroxime were approved, namely for the medicinal product Zinnat™ (dosage form: film-coated tablets of 125 mg, 250 mg, 500 mg; granules for suspension of 125 mg, granules for preparing 100 ml (250 mg/5 ml) of suspension, granules for preparing 100 ml (125 mg/5 ml) of suspension), applicant GlaxoSmithKline Export Limited (United Kingdom), with amendments made to the section of the instructions “Indications” (removal of a therapeutic indication) and, as a consequence, changes made to the section “Method of administration and dosage”.

Other materials in this section